Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.
Advertisement
News & Opinion
Covering the life sciences inside and out
Most Recent
From breast milk stem cells to bone repair, this year’s EB conference held a number of exciting advances that could one day be translated into therapies.
Editors at PLoS Medicine suggest that merely disclosing conflicts of interest is insufficient and possibly even counterproductive.
With 12 new tuberculosis vaccines in clinical development, a plan is needed to introduce the most effective ones throughout the world.
A once rare mobile genetic element could be the cause of a MRSA epidemic in Chinese hospitals.
A mosquito-killing fungus shows promise as an effective dengue-control agent.
Remarkable findings of ingested plant miRNA in animal liver and blood draw speculation about the study’s validity.
A study of children in Tanzania links iron deficiency with fewer malaria infections.
Pulling frequent all-nighters, experiencing jet lag, and working night shifts can lead to diabetes in more than one way.
A roundup of recent research announced this week at the annual conference of the American Association for Cancer Research (AACR).
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- genetics & genomics
- neuroscience
- opinion
- techniques
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
